Robert W. Baird initiated coverage on Alignment Healthcare with a new price target
$ALHC
Medical Specialities
Health Care
Robert W. Baird initiated coverage of Alignment Healthcare with a rating of Outperform and set a new price target of $10.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/3/2024 | $13.00 → $17.00 | Equal-Weight → Overweight | Stephens |
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets | |
| 5/30/2024 | $10.00 | Outperform | Robert W. Baird |
| 5/30/2024 | $7.75 → $11.00 | Neutral → Buy | BofA Securities |
| 5/8/2024 | $6.00 → $8.00 | Neutral → Overweight | Piper Sandler |
| 3/6/2024 | $4.50 | Underweight | Barclays |
| 3/6/2024 | $12.00 → $6.00 | Overweight → Neutral | Piper Sandler |
| 1/24/2024 | $11.00 | Buy | Stifel |
Stephens upgraded Alignment Healthcare from Equal-Weight to Overweight and set a new price target of $17.00 from $13.00 previously
KeyBanc Capital Markets initiated coverage of Alignment Healthcare with a rating of Sector Weight
Robert W. Baird initiated coverage of Alignment Healthcare with a rating of Outperform and set a new price target of $10.00
4 - Alignment Healthcare, Inc. (0001832466) (Issuer)
Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership, revenue, adjusted gross profit and adjusted EBITDARaises midpoint of outlook ranges for 2025 year-end membership, revenue, adjusted gross profit and adjusted EBITDA, supported by strong first-quarter clinical performance and enrollment growth momentumAnnounces transition of Thomas Freeman from Chief Financial Officer (CFO) to Strategic Advisor to the CEO; names finance veteran Jim Head as CFO ORANGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today reporte
ORANGE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), will release its first quarter 2025 financial results on Thursday, May 1, 2025, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EDT. Conference Call DetailsA live audio webcast will be available online at https://ir.alignmenthealth.com/. At the start of the conference call, participants may access the webcast at the following link: https://edge.media-server.com/mmc/p/frtkwokr A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same web links and will
Reports 189,100 health plan members as of Dec. 31, 2024, up 58.6% year-over-year, beating year-end expectationsAchieves first full year of positive adjusted EBITDA as a public company, driven by operating leverage and strong medical benefits ratio performanceRaises midpoint of 2025 health plan membership guidance by 2,000 to reflect strong open enrollment period momentumIntroduces 2025 revenue guidance of $3.72 billion to $3.78 billion, representing 37.6%-39.6% growth year-over-year, and adjusted EBITDA of $35 million to $60 million ORANGE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today reported financial results for its fourth quarter and full y
SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)
SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)
SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)